CTRI/2018/08/015152已完成未知
To study the effect of post-transplant cyclophosphamide pharmacokinetics and pharmacogenetics with transplant outcomes and immune reconstitution in patients undergoing haploidentical hematopoietic stem cell transplantation for acute leukemia
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients receiving either myeloablative or reduced intensity conditioning.
- •2. Patients receiving post-transplant cyclophosphamide as a part of haploidentical transplantation.
- •3. Patients consenting for study.
排除标准
- •1. Patients not willing for haploidentical hematopoietic cell transplantation
- •2. Patients who are unable to follow up for one year.
- •3. Patients not a candidate for haploidentical HCT or as deemed unfit for HCT by treating
- •physician as per established unit protocol
- •4. Patients other than acute leukemia undergoing haploidentical HCT
研究者
相似试验
已完成
3 期
Post -transplantation Cyclophosphamide as Graft Versus Host Disease prophylaxis in Children with ß-Thalassemia Major undergoing Hematopoietic Stem Cell TransplantatioPACTR202311877246623faculty of medicine tanta university30
已完成
2 期
Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDSMyelodysplastic SyndromesNCT02969980Asan Medical Center30
已完成
不适用
Posttransplantation cyclophosphamide and tacrolimus for prevention of Graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from HLA matched sibling or unrelated donor: a single center prospective phase II study (OCU16-1)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia(ALL) Acute leukemias of ambiguous lineage Myelodysplastic syndrome(MDS) Chronic myeloid leukemia(CML) Malignant lymphoma(ML)JPRN-UMIN000023890Osaka City University39
招募中
2 期
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological MalignanciesBone Marrow Transplant ComplicationsGraft Versus Host DiseaseInfection ViralEngraft FailureImmunologic SuppressionNCT03818334Hospital Israelita Albert Einstein50
已完成
2 期
Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell TransplantationNon-Hodgkin-LymphomaMultiple MyelomaHodgkin's DiseaseNCT01283776University of Cologne11